ALX Oncology Holdings Inc. (ALXO) Misses Q2 EPS by 6c

ALX Oncology Holdings Inc. (NASDAQ: ALXO) reported Q2 EPS of ($0.49), $0.06 worse than the analyst estimate of ($0.43).

For earnings history and earnings-related data on ALX Oncology Holdings Inc. (ALXO) click here.

You May Also Be Interested In

• FTC to file lawsuit alleging Amazon deceived advertisers - WSJ
• The Trade Desk Inc. (TTD) Climbs on Report FTC To File Lawsuit Alleging Amazon Deceived Advertisers
• BridgeBio Pharma (BBIO) PT Raised to $110 at Mizuho